Compositions containing alpha-2-adrenergic agonist components

  • US 6,641,834 B2
  • Filed: 09/06/2002
  • Issued: 11/04/2003
  • Est. Priority Date: 07/14/2000
  • Status: Expired due to Term
First Claim
Patent Images

1. A therapeutically effective aqueous ophthalmic composition comprising:

  • up to about 0.15% (w/v) of 5-bromo-6-(2-imidozolin-2-ylamino) quinoxaline tartrate, the composition having a pH of about 7.0 or greater, and the 5-bromo-6-(2-imidozolin-2-ylamino) quinoxaline tartrate being soluble in the composition at about 21°

    C.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×